Ohio State Navbar

Directory

Steven Devine, MD


Staff photo

320 W 10th Ave
Columbus, OH 43210

Phone: (614) 293-5655

Email: devine.54@osu.edu

 

Current OSU Appointments

Professor, Hematology

Physician, FGP-Hematology

 

Licenses

1990 - present Diplomate: American Board of Internal Medicine
1993 - present Diplomate: American Board of Internal Medicine
 

Chapters in Books

Hematological malignancies

Non-human Primate Models of Stem Cell Transplantation

Patient Evaluation Before Transplantation

Novel Approaches to Stem Cell Mobilization

 

Clinical Services

08/01/2012 BMT Inpatient Service (James Cancer Hospital)
01/01/2013 BMT Inpatient Service (James Cancer Hospital)

Degrees

1983 B.S., Boston College

1987 M.D., University of Massachusetts

 

Editorial Activities

present Leukemia
present Leukemia and Lymphoma
2007 Haematologica
2007 Gene Therapy
2007 Nature Medicine
2007 Blood
2007 Experimental Hematology
2007 Journal of Hematotherapy
2007 Bone Marrow Transplantation
2007 Journal of Clinical Oncology
2007 Biology of Blood and Marrow Transplantation
2009 - present American Society of Hematology
2009 - 2005 American Society Hematology
2010 - present Biology of Blood and Marrow Transplantation
 

Honors

1982 Alpha Sigma Nu. Boston College.
1983 Phi Beta Kappa. Boston College.
1987 Alfred Pick Award for Academic Excellence. University of Massachusetts Medical School.
2000 Best Abstract, First Annual Mesenchymal Stem. international Society of Cellular Therapy.
2001 Cell Symposium Plenary Session Abstract Presenter, International. International Society of Cellular Therapy.
2005 - present Best Abstract Session, International Society of Cellular Therapy.
2007 - present America's Best Doctors. U.S. News & World Report.
2007 - 2009 "Top Docs" in US.
2008 - present ASBMT Board of Directors.
2008 - 2010 Voted as one of the "Best Doctors" in Columbus.
2009 - present NCI Clinical Investigator Team Leadership Award. National Cancer Institute.
2009 - present Bertha Bouruncle Faculty Teaching Award. Internal Medicine/Division of Hematology and Oncology.
 

Journal Articles

null

. -.

null

"Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: Results from the expanded access program." Bone Marrow Transplantation. Vol. 48, no. 6. (June 2013.): -.

 

Reference Works

November 2005 Wildes TM, Augustin KM, Ravi V, Bartlett N, DiPersio NF, Devine SM.."Comparison of Outcomes in Elderly Patients with Non-Hodgkins Lymphoma Undergoing High-Dose Chemotherapy to Their Younger Counterparts: Greater Morbidity but No Significant Impact on Overall Survival." . : 2086
November 2005 Devine SM, Andritsos LA, Todt L, Ravi V, Bonde J, Hess D, Nolta J, Link D, Bridger G, Calandra G, DiPersio JF.."A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies." . : 299
November 2005 Andritsos L, Augustin K, Ravi V, DiPersio JF, Devine SM.."Acute GVHD May Play a Role in Preventing Relapse Following Reduced Intensity Allografts for Acute Myeloid Leukemia." . : 1807
February 2005 Uy GL, Fisher NM, Devine SM, Adkins DR, Tomasson MH, Graubert TA, DiPersio JF, Vij R.."Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation." . : 77
November 2005 Shachar P, Fisher NM, Gao F, Devine SM, Tomasson MH, DiPersio JF, Ravi V.."Once Weekly Bortezomib (Velcade) Preserves Bone Health by a Direct Effect on Osteoclast Function Independent of Its Effect on the Malignant Plasma Cells." . : 3458
November 2005 Fong T, Trinkaus K, Adkins DR, Ravi V, Devine S, Tomasson M, Goodnough LT, Graubert T, Shenoy S, DiPersio JF, Khoury HJ.."A Randomized, Double Blind Trial of Hydroxychloroquine for the Presention of Grant-ersus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation." . : 1800
February 2005 Andritsos LA, Edwards T, Sempek D, Calandra G, Badel K, Vij R, DiPersio JF, Devine SM.."A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies." . : 5
November 2005 Cashen A, Devine S, Ravi V, DiPersion J.."AMD3100+G-CSF Improves Hematopoietic Progenitor Cell (HPC) Collection in Patients with Hodgkin's Disease (HD)." . : 1979
November 2005 Walter MJ, Ries RR, Li D, Shannon WJ, Payton J, Bloomfield CD, Mrozek K, ruppert AS, DiPersio J, Link D, Tomasson M, Graubert T, McLeod H, Devine SM, Watson M, Heath S, Baty J, Trinkaus K, Armstrong J, Mardis E, Wilson R, Selzer R, Richmond T, Eis P, Ley TJ.."Detection of Microdeletions and Amplifications in Primary Human Acute Myeloid Leukemia (AML) Genomes Using Ultradense Oligomer Tiling Path Arrays and Comparative Genomic Hybridization (CGH)." . : 2350
November 2005 Uy GL, Holt MS, Fisher NM, Devine SM, Tomasson MH, DiPersio JF, Ravi V.."Bortezomib Alters Peripheral Blood Lymphocyte Subsets in Patients with Multiple Myeloma." . : 2387
November 2005 Shachar P, Risher NM, Devine SM, Tomasson MH, DiPersio JF, Ravi V.."Bortezomib (Velcade) When Given Pretransplant and Once Weekly as Consolidation Therapy Following High Dose Chemotherapy (HDCT) Leads to High Rates of Reactivation of Varicella zoster Virus (VZV)." . : 3237
November 2005 Hess DA, Wirthlin L, Craft TP, Bonde J, Lahey RW, Hohm SA, Herrbrich PE, DiPersio JF, Devine SM, Nolta JA.."Human CD34+Cells Mobilized by AMD3100Demonstrate EnhancedNOD/SCID Repopulating Function Compared to CD34+Cells Mobilized by Granulocyte Colony Stimulating Factor." . : 1962
November 2006 Bashey A, Owzar K, Johnson JL, Devine SM, Shadduck RK, Shea TC, Linker C.."Reduced-Intensity Allogeneic Transplantation after Failure of Autologous Transplantation: A Prospective Multi-Center CALGB Study." . : 3122
February 2006 Tiward D, Vij R, Devine S, DiPersio J, Khoury HJ.."Does GM-CSF alter the prognostic significance of early lymphocyte recovery post-autografting for NHL?" . : 99
February 2006 Devine SM, Todt L, Bonde J, Hess D, Devine H, Nolta J, Link D, Calandra G, Bridger G, DiPersio JF.."A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies." . : 35
February 2006 Cashen AF, Devine S, Vij R, DiPersio J.."AMD3100 + G-CSF improves hematopoietic progenitor cell (HPC) collection in patients with hodgkin's disease (HD)." . : 92
November 2006 Devine SM, Ravi V, Todt L, McLaughlin K, Fisher N, Morris N, Link DC, Calandra G, Bridger G, DiPersion JF.."HLA-Matched Sibling Donor Stem Cell Mobilization Can be Safecly and Effectively reduced from a Five Day to a One Day Process by a Direct antagonist of the CXCR4/SDF-1 Interaction." . : 53
November 2006 Crawford RD, Krugh D, Blum W, Devine S.."Transplantation without Hemolysis in a Kell Antigen Positive Patient Undergoing Peripheral Hematopoietic Stem Cell Transplant from a Donor with Anti-Kell Antibodies." . : 4137
November 2006 Rettig M, Devine SM, Ritchey J, DiPersio JF.."Phenotypic and Functional Analysis of T-Cells Mobilized in HLA-Matched Sibling Donors Following Treatment with the Chemokine Antagonist AMD3100." . : 3001
November 2006 Reddy V, Vaughan W, Devine S, Rowley SD, Wallker N, Devetten M, Schiller GJ.."A Pilot Trial of Two dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell transplant (SCT) with Cyclosporine (CsA) as Grant Versus Host Disease ...." . : 5369
February 2007 Rice JM, Sirilla JA, Krugh DW, Crawford R, Benson DM, Devine SM.."404: Surveillance, evaluation and management of passenger lymphocyte syndrome." . : 145
November 2007 Andritsos L, Hamadani M, Heerema NA, Benson D, Hofmeister CC, Blum W, Flynn J, Jones JA, Elder P, Lin TS, Lozanski G, Byrd JC, Devine S.."Attainmnet of Minimal Residual Disease negative State Is Crucial for Successful Outcome of Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Advanced Chronic Lymphocytic Leukemia (CLL)." . : 2170
November 2007 Hamadani M, Elder P, Awan F, Krugh D, Blum W, Lin T, Andritsos L, Bechtel T, Blum K, Klisovic R, Devine SM.."High Rates of Early Donor Chimerism and Low Risk of Chronic GVHD Can Be Achieved in Poor Risk Patients Undergoing Unrelated Donor Stem Cell Transplantation Using a Reduced Intensity Conditioning regimen Incorporating Fludarabine, busulfan and Rabbit ATG." . : 5080
November 2007 Hamadani M, Awan F, elder P, Porcu P, Lin T, Blum K, Scholl D, Devine SM.."Allogeneic Hematopoietic Stem Cell Transplantation for peripheral T-Cell Lymphoma: Evidence of Granft-Versus-Lymphoma Effect." . : 3044
November 2008 Blum W, Klisovic R, Liu S, Garzon R, Kefauver C, Liu Z, Mickle J, Devine H, Devine S, Grever MR, Chan KK, Villalona-Calero M, Byrd JC, Marcucci G.."Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single" . : 2957
February 2008 Bechtel TP, Crawford BS, Gordon SM, Penza S, Hofmeister C, Benson D, Devine S.."471: An aprepitant containing Regimen Controls the Delayed Nausea and vomiting Associated with High-dose Melphalan followed by autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myloma." . : 166
February 2008 Hamadani M, Phillips G, Elder P, Jansak B, Blum W, Penza S, Lin TS, Farag SS, Devine SM.."356: Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)." . : 130-131
November 2008 Blum KA, Liu Z, Lucas DM, Baiocchi R, Lin TE, Benson D, Devine SM, Jones J, Andritsos L, Flynn JM, Cheng P, Xie Z, Marcucci G, Chan KK, Grever MR, Byrd JC.."A Phase I Evaluation of Low Dose Decitabine Targeting DNA Hypermethylation in Patients with Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL):Dose-Limiting Myelosuppression without Evidence of Hypomethylation." . : 3169
February 2008 Hamadani M, Awan FT, Elder P, Lin TS, Andritsos L, Blum W, Blum KA, Devine SM.."310: Rapid Engraftment and Low Rates of Grast-versus-host Disease (GVHD) Following Reduced Intensity Conditioning (RIC) with Fludarabine/Busulfan/ATG (FBA) and Stem Cell Transplantation (SCT) using Unrelated Donors (URD)" . : 114-115
November 2008 Benson D, Andritsos L, Hamadani M, Lin T, Flynn J, Jones J, Blum W, Elder P, Lozanski G, Byrd J, Devine S.."Natural Killer Cell Immune Reconstitution Predicts Outcomes for Patients with Chronic Lymphocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation." . : 3300
November 2008 Hamadani M, Blum KA, Elder P, Lin TS, Porcu P, Hofmeister C, Blum W, Marcucci G, Benson D, Devine S.."Allogeneic Stem Cell Transplantation for Patients with Chemo-Refractory of Progressive Aggressive Non-Hodgkin's Lymphomas." . : 3265
November 2008 Hamadani M, Blum W, Benson D, Blum KA, Porcu P, Elder P, Krugh D, Bechtel T, Andritsos L, Garzon R, Penza S, Lin TS, Devine SM.."Assessment of Rabbit Antithymocyte Globulin (rATG) Dose-Intensity in Patients with Hematological Malignancies Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Reduced Intensity Conditioning (RIC) with Fludarabine, Busultan and rATG (FBA)." . : 4405
February 2009 Hamadani M, Benson DM, Porcu P, Elder P, Andritsos L, Hofmeister CC, Krugh D, Garzon R, Lin T, Marcucci G, Blum W, Devine SM.."Evaluation of Rabbit Antithymocyte Globulin (rATG) Dose-intensity in Patients Undergoing Allogeneic Stem Cell transplantation (ASCT) Following Reduced Intensity conditioning (RIC) with Fludarabine, Busulfan and rATG (FBA)." . : 5
February 2009 Bechtel TP, Devine S."Use of a Calcium/Phosphate Oral Rinse (Caphosol®) to Lessen the Mucositis Following Autologous Peripheral Blood Stem Cell Transplantation." . : 154
February 2009 Benson DM, Hofmeister CC, Hamadani M, Panzner K, Smith MK, Penza SL, Elder P, Krugh D, O'Donnell L, Devine SM.."Pre-Mobilization Bone Marrow Plasmacytosis Predicts Successful Stem Cell Mobilization in Patients with Multiple Myeloma Receiving Lenalidomide-Based Induction regimens." . : 67-68
November 2009 Blum W, Klisovic RB, Walker A, Garzon R, Liu S, Schaaf LJ, Humphries K, Grever MR, Devine S, Byrd JC, Marcucci G.."Methyltransferase: A Phase I Study of Bortezomib in Combination with 5-Azacytidine in Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)." . : 2065
November 2009 Devine SM, Soiffer RJ, Pasquini MC, Carter S, Hari PN, DeVore S, Stein A, Lazarus HM, Linder C, Stadtmauer EA, Keever-Taylor CA, O'Reilly RJ.."HLA-Identical Sibling-Matched, CD235+ Selected, T Cell Depleted Peripheral Blood Stem Cells Following Myeloablative Conditioning for First or Second Remission Acute Myeloid Leukemia (AML): Results of Blood and Marrow transplant Clinical Trials Network (BM" . : 655
February 2009 Hamadani M, Baiocchi R, Lin T, Blum KA, Ezzone S, Benson DM, Devine SM.."Feasibility of Allogeneic peripheral Blood stem Cell Transplantation (Allo-SCT) Following reduced Intensity Conditioning (RIC) in HIV+ Patients with Hematological Malignancies." . : 113
November 2009 Chandler JC, Klisovic RB, Phelps MA, Walker A, Garzon R, Yang X, Schaaf L, Schwind S, Becker, Liu S, Hickey C, Kefauver C, Mickle J, Devine SM, Grever MR, Byrd JC, Marcucci G, Blum W.."Phase I Study of Lenalidomide in Acute Leukemia: Remissions in Post-Allogeneic Relapse of Acute Myeloid Leukemia." . : 841
February 2009 Grauer A, Hamadani M, Blum KA, Porcu P, Benson DM, Devine SM.."Allogeneic Versus Autologous Stem Cell Transplantation (SCT) for Follicular Lymphoma (FL). The James Comprehensive Cancer Center Experience." . : 132
November 2009 Mahindra A, Bolwell BJ, Dean R, Kalaycio M, Avalos B, Rybicki L, Tench S, Elder P, Sobecks R, Sweetenha J, Pohlman B, Andresen S, Devine S, Copelan E.."Etoposide Priming in Patients with Lymphoma Improves Mobilization without An Increased Risk of Secondary Hematologic Malignancies." . : 2264
November 2009 Benson D, Bakan CE, Alghothani L, Hofmeister CC, Efebera YA, Smith MK. Greenfield CN, Andre P, Squiban P, Romagne F, Caligiuri MA, Devine SM.."Characterization of Early Natural Killer Cell Reconstitution following autologous transplantation in Multipe Myeloma." . : 4641
November 2009 Jaglowski SM, Lin TS, Elder P, Scholl D, Byrd JC, Devine SM.."Barriers to Reduced-Intensity Conditioning (RIC) Transplant in Patients with Chronic Lymphocytic Leukemia." . : 1374
November 2009 Rotem-Yehudar R, Armand P, Devine S, Fay JW, Hosing C, Mapara MY, Campagnero E, Uberti JP, Avigan D, Ballen KK, Winter JN, Nagler A, Gordon LI.."The Humanized Anti PD-1 Antibody, CT-001, Increases specific CD4+Effector/Memory and Memory T Lymphocytes in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Following Autologous Stem Cell transplantation (AuSCT)." . : 1216
November 2009 Farag S, Owzar K, Hars V, Lazarus HM, Stadtmauer EA, Devine SM, van Besien K, Linker C.."A Prospective Multicenter Phase II Trial of Pentostatin in Adult patients with Steroid-Refractory Chronic Graft-Versus-Host Disease (cGVHDD): A Cancer and Leukemia Group b/Eastern Cooperative Oncology Group Study." . : 2238
November 2009 Blum W, Klisovic RB, Walker A, Garzon R, Liu S, Schaaf LJ, Humphries K, Grever MR, Devine SM, Byrd JC, Marcucci G.."Epigenetic Targeting Via Transcriptional Inhibition of DNA Methyltransferase: a Phase I Study of Bortezomib in Combination with 5-Azacytidine in Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)." . : 2065
December 2010 McCarthy PL, Owzar K, Anderson KC, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Richardson PG, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Hars V, Postiglione J, Jiang C, Bennett E, Barry SS, Bressler L, Kelly M, Sexton M, Rosenbaum C, Parameswaran H, Pasquini MC, Horowitz MM, Shea TC, Devine S Linder C.."Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Folowing Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104." . : 21
January 2010 Hofmeister CC, Rieser G, Bowers MA, Merritt LC, Greenfield CN, Efebera YA, Benson DM Jr, Devine S, de Moor JS.."Tablet-Based Assessment of Fatigue, Depression and Pain in Myeloma Patients: Cohort Study of Inflammatory Cytokines and QOL Measures in the Newly Diagnosed, Patients on Lenalidomide and Survivors." . : 1557
December 2010 Stauffer N, Hamadani SM, Heaphy C, Santhanam R, Sandhu S, Costinean S, Nuovo J, Perrotti D, Croce CM, Hadley G, Marcucci S, Devine S, Garzon R.."Regulation of Acute Graft-Versus-Host Disease by Micro RNA-155." . : 113
January 2010 Jaglowski SM, Flynn JM, Jones JA, Lin TS, Fischer B, Scholl D, Elder P, Devine S, Grever MR, Byrd JC, Andritsos LA.."Flavopiridol is an Effective Therapy to Bridge Patients with Chronic Lymphocytic Leukemia (CLL) to Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant." . : 987
January 2010 Blum W, Klisovic RB, Garzon R, Walker A, Schwind S, Liu S, Schaaf L, Garr C, Devine S, Grever MR, Byrd JC, Marcucci G.."A Phase 1 Trial of decitabine and Bortezomib in High Risk Acute Myeloid Anemia (AML)" . : 1349
December 2010 Habis J, Dunavin N, Philips G, Elder P, Tranovich M, Benson DM Jr, Hofmeister CC, Byrd JC, Devine S, Efebera Y.."Analysis of 179 Patients with newly diagnosed Multiple Myeloma (MM) Treated with Novel Agents followed by autologous Stem Cell transplantation (ASCT): a Retrospective Study" . : 575
January 2010 Armand P, Perez W, Zhang MJ, Kim H, Klumpp TR, Dal Cin P, Walker EK, Litzow MR, Liesveld JL, Lazarus HM, Artz A, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten H, Finke J, Ball ED, Aljiurf M, Cutler C, Rowe JM, Antin JH, Isola LM, Di Bartholomeo P, Camitta B, Miller AM, Cairo MS, Stockerl-Goldstein KE, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes D, Petersdorf EW, Devine S, Maziara R, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer R, Weisdorf DJ.."Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation in AML: A CIBMTR Study." . : 299
December 2010 Soiffer RJ, LeRademacher J, Ho VT, Kan F, Artz A, Champlin R, Devine S, Lazarus HM, Marks DI, Porter D, Waller EK, Horowitz MM, Eapen.."Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies." . : 951
November 2012 Devine S, Owzar K, Blum W, DeAngelo D, Stone RM, Hsu JW, Champlin RE, Chen YA, Vij R, Slack JL, Soiffer RJ, Larson RA, Shea TC, Hars V, Bennett E, Spangle S, Giralt SA, Carter SL, Horowitz MM, Linker C, Alyea EP.."A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 05802" .

Presentations

Stem Cell Plasticity

Mesenchymal Stem cell Transplantation

Advances in Allogeneic Stem Cell Transplantation

Mesenchymal Stem Cell Transplantation

Advances in Allogeneic Stem Cell Transplantation

Advances in Allogeneic Transplantation

Hematological Malignancies

Graft Versus Host Disease

Hematological Malignancies

Pulmonary Complications of Stem Cell Transplantation

Ethics of Stem Cell Research

Advances in Allogeneic Stem Cell Transplantation

Advances in Allogeneic Stem Cell Transplantation

Stem Cell Transplantation of Acute Myeloid Leukemia

Mobilized Blood Cells for Allogeneic Transplantation

Improving Stem Cell Mobilization by CXCR4 Antagonism

Improving Stem Cell Mobilization by CXCR4 Antagonism

Mobilization of Allogeneic Stem Cells

Stem Cell Mobilization

Mobilization of Hematopoietic Stem Cells in Normal Volunteers

Stem Cell Transplantation

Stem Cell Transplantation

Improving Stem Cell Mobilization by CXCR4 Antagonism

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Novel methods of stem cell mobilization

Fungal infections in recipients of blood and marrow transplant

Poster: A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietics stem cells in patients with advanced hematological malignancies

Advances in the treatment of chronic myeloid leukemia

Current approaches to treating acute myeloid leukemia (AML) in the elderly

Current approaches to treating acute myeloid leukemia (AML) in the elderly

Advances in allogenic transplantation

Improving stem cell mobilization by targeting CXCR4

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia (AML)

Advances in allogenic transplantation

Improving stem cell mobilization by CXCR4 antagonism

Stem cell transplantation

Improving stem cell mobilization by targeting CXCR4

Improving stem cell mobilization by targeting CXCR4

Update in CML management

Update in CML management

Advances in allogenic stem cell transplantation

Recent development in acute myeloid leukemia

T-depleted transplant for AML

Treatment of myeloid malignancies

CXCR4 antagonist to enhance stem cell mobilization

Update on CML management

CXCR4 antagonist to enhance stem cell mobilization

Update on CML Management

Allogeneic stem cell transplantation for hematologic malignancies

Current and potential therapeutic applications of AMD3100

Allogeneic cell transplantation for acute myeloid leukemia

Hematopoietic stem cell transplantation in myeloidysplastic syndrome

Update on stem cell mobilization for patients and donors

Novel applications of the CXCR4 antagonist plerixafor

New Mobilization Approaches in Allogeneic Transplantation

Update on CML management

A single arm multi-center phase II trial of transplants of HLA-matched, CD34+ enriched, T-cell depleted peripheral blood stem cells isolated by the CliniMACS system in the treatment of patients with AML in first or second complete remission.

Update on stem cell mobilization for patients and donors

Advances in stem cell mobilization for patients and donors

Influence of graft content on outcomes in autologous and allogeneic transplantation

New Approaches to Stem Cell Mobilization

Frontline Treatment for Multiple Myeloma: Current Options for Initial Therapy.

Reduced intensity allogeneic transplantation in patients with myeloid diseases: are we making progress?

Recent Developments in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

Improving Stem Cell Mobilization by Targeting CXCR4

Treating special populations of patients with multiple myeloma.

Improving Outcomes of Allogeneic transplantation in Patients with Acute Leukemia.

Allogeneic Hematopoietic Cell Transplantation for cutaneous Lymphoma

Can we Define Reduced Intensity Conditioning?

Improving stem cell mobilization outcomes.

T-cell depleted transplantation for AML

Frontline Treatment for Multiple Myeloma: Current Options for Initial Therapy"

Improving stem cell mobilization outcomes.

Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF)L Results of a Treatment IND Expajded Access Protocol

Can blood cell transplantation be improved by modifying the mobilization regimen?

Overcoming Challenges and Examining Opportunities in Improving Stem Cell Mobilization Outcomes

Thymoglobulin in HSCT: OSU and CALGB Experience

Role of Maintenance Therapy in Multiple Myeloma

Clinical Allogeneic and Autologous Transplantation - Results: Novem Regimes and Prognostic Scoring

N/A

S-O-A-B Oral Abstracts Session B - Autologous

GVHD Prevention thru T-Cell Depletion: What have we learned?

N/A

ADMIN-12 Cost Savings Measures through Collaboration

Transplantation for older patients with AML: who benefits?

Update on Bone Marrow Transplantation for Turkish Hematologists

A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies

Recent advances in management of acute myeloid leukemia (AML).

HLA-matched sibling donor stem cell mobilization can be safely and effectively reduced from a five day to a one day process by a direct antagonist of the CXCR4/SDF-1 interaction.

Hematopoietic stem cell transplantation in Oman

A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies.

TREATMENT OF ELDERLY PATIENTS

 

Professional Activities

2002 - present NMDP Meeting. National Marrow Donor Program. Minneapolis, MN.
2002 - present Marilyn Fixman Lecture. Barnes-Jewish Hospital. St. Louis, MO.
2002 - present Medical Grand Rounds. Washington University. St. Louis, MO.
2002 - present Cook County Hospital Medical Grand Rounds. Cook County Hospital. Chicago, IL.
2003 - present American Society of Hematology Review. Washington University. St. Louis, MO.
2004 - present American Society of Clinical Oncology Review. American Society of Clinical Oncology. St. Louis, MO.
2004 - present Washington University Ethics Forum. Washington University. St. Louis, MO.
2004 - present Pulmonary Grand Rounds. Washington University. St. Louis, MO.
2004 - present University of Missouri Hematology Grand Rounds. University of Missouri. St. Louis, MO.
2004 - present Medical Grand Rounds. Washington University. St. Louis, MO.
2005 - present American Society of Hematology Super Friday Symposium. American Society of Hematology. Atlanta, GA.
2005 - present American Society of Hematology Meeting. American Society of Hematology. Atlanta, GA.
2005 - present Cincinnati Childrens Hospital Grand Rounds. Cincinnati Childrens Hospital. Cincinnati, OH.
2005 - present University of British Columbia BMT Grand Rounds. Improving Stem Cell Mobilization by CXCR4 Antagonism. Vancouver, BC.
2005 - present University of Alberta BMT Grand Rounds. University of Alberta. Calgary, AB.
2005 - present American Association of Blood Banks Audioconference. American Association of Blood Banks. Columbus, OH.
2005 - present University of Florida BMT Grand Rounds. University of Florida. Gainesville, FL.
2005 - present Medical College of Wisconsin BMT Grand Rounds. Medical College of Wisconsin. Milwaukee, WI.
2005 - present American Society of Clinical Oncology Review. American Society of Clinical Oncology. St. Louis, MO.
2005 - present ASBMT/CIBMTR Annual Meeting. ASBMT/CIBMTR. Keystone, CO.
2005 - present 2005 Berlex Medical Affairs Meeting. Berlex, Inc.. St. Louis, MO.
2005 - present National Marrow Donor Program Council Meeting. National Marrow Donor Program. Minneapolis, MN.
2005 - present American Society of Hematology Review. American Society of Hematology. St. Louis, MO.
2005 - present Hematology Grand Rounds. Carle Clinic. Urbana, IL.
2006 - present Anormed Dinner Program. University of Pennsylvania Medical Center. Philadelphia, PA.
2006 - present Chillicothe VA Lecture. VA Hospital. Chillicothe, OH.
2006 - present BMT CTN Steering Committee Meeting. BMT CTN. Minneapolis, MN.
2006 - present Wyandott Memorial Tumor Board. Wyandott Memorial Hospital. Upper Sandusky, OH.
2006 - present Bucyrus Community Hospital Medical Staff. Bucyrus Community Hospital. Bucyrus, OH.
2006 - present Round Table Dinner. Yale University School of Medicine. New Haven, CT.
2006 - present Pathology Grand Rounds. The Ohio State University Medical Center. Columbus, OH.
2006 - present Fellows Lecture. The Ohio State University Medical Center. Columbus, OH.
2006 - present Novartis Dinner Program. Novartis. Barbourville, WV.
2006 - present Novartis Dinner Program. Novartis. Columbus, OH.
2006 - present Columbus Chapter of the Oncology Nursing Society. Recent advances in treatment of acute myeloid leukemia. Columbus, OH.
2006 - present BMT Grand Rounds. Moffit Cancer Center. Tampa, FL.
2006 - present Annual American Society of Hematology Review Meeting. American Society of Hematology. Columbus, OH.
2006 - present American Society of Hematology Meeting. American Society of Hematology. Orlando, FL.
2006 - present Oncology Best Practices 2006. The Ohio State University. Columbus, OH.
2006 - present ASBMT Tandem Meeting. ASBMT. Honolulu, HI.
2006 - present Bone Marrow Transplantation Series. The Ohio State University. Columbus, OH.
2006 - present Super Friday Symposium. American Society of Hematology. Orlando, FL.
2007 - present Novartis Dinner Program. Novartis. Charleston, WV.
2007 - present Midwest Blood Club Meeting. Midwest Blood Club. Cincinnati, OH.
2007 - present Good Samaritan Hospital Tumor Board. Genesis Health Care System. Zanesville, OH.
2007 - present A.G. Edwards Dinner. Boston, MA.
2007 - present Ohio State University Comprehensive Cancer Center Hem/Onc Review. Update on CML Management. Columbus, OH.
2007 - present Piedmont Oncology Association Program Committee. Wake Forest University. Myrtle Beach, SC.
2007 - present Genzyme Advisory Board. Genzyme. Boston, MA.
2007 - present Genzyme Advisory Board. Genzyme.
2007 - present BMT Tandem Meeting. ASBMT Tandem Meetings. Keystone, CO.
2007 - present Update on Treatment of Hematological Treatment. The Ohio State University. Columbus, OH.
2007 - present Ohio State University Comprehensive Transplant Program Conference. The Ohio State University. Columbus, OH.
2008 - present 2008 BMT Tandem Meeting. ASBMT. San Diego, CA.
2008 - present ISCT 2008 Meeting. International Society for Cellular Coverage. Miami, FL.
2008 - present ISCT 2nd Regional Meeting. International Society for Cellular Therapy. Columbus, OH.
2009 - present Canadian Apheresit Group Annual Meeting. Canadian Apheresis Group. Ottawa, ON.
2009 - present Satellite Symposium. National Marrow Donor Program. New Orleans, LA.
2009 - present Cutaneous Lymphoma Summit Meeting. New York City, NY.
2009 - present Case Western Blood Club. Ireland Cancer Center. Cleveland, OH.
2009 - present Satellite Symposium. CIBMTR-ASBMT Tandem BMT Meetings. Tampa, FL.
2009 - present Audioconference, Update on Allogeneic Hematopoietic Cell Transplantation. AABB. Columbus, OH.
2010 - present CALGB Fall Meeting. Cancer & Leukemia Group B Clinical Research Group. Chicago, IL.
2010 - present BMT/CTN Steering Committee Meeting. Blood and Marrow Transplant Clinical Trials Network. Arlington, VA.
2010 - present Data Patient Safety Monitoring Meeting. National Marrow Donor Program. Minneapolis, MN.
2010 - present Blood and Marrow Transplant Clinical Trials Myeloma Intergroup Meeting. Blooc and Marrow Transplant Clinical Trials Network. Minneapolis, MN.
2010 - present Genzyme Ad Board Meeting. Genzyme. Orlando, FL.
2010 - present CALGB 2010 Spring Meeting. Cancer & Leukemia Group B Clinical Research Group. Raleigh, NC.
2011 - present CALGB Fall Group Meeting. Cancer & Leukemia Group B Clinical Research Group. Miami, FL.
2011 - present Satellite Cymposium. Kiadis Pharma.
2011 - present Engraftment Study Discussiong. GlaxoSmithKline. Boston, MA.
2011 - present DPSM Committee Meeting. National Marrow Donor Program. Minneapolis, MN.
2011 - present Investigator Update: ASH 2010. Genzyme Transplant Oncology.
2011 - present Genzyme Advisory Board Meeting/Thymoglobulin in Hematopoietic Stem Cell Transplantation. Genzyme. Honolulu, HI.
2011 - present
2011 - present CALGB Board of Directors Meeting. Cancer & Leukemia Group B Clinical Research Group. Chicago, IL.
2002 American Society for Apheresis Meeting. Orlando, FL.
2008 European Bone Marrow Transplant Symposium.
2008 The Leukemia & Lymphoma Society MDS Program. The Leukemia & Lymphoma Society. Columbus, OH.
2009 51st ASH Annual Meeting and Exposition. American Society of Hematology. New Orleans, LA.
2010 BMT Tandem Meetings. ASBMT/CIBMTR. Orlando, FL.
2010 52nd ASH Annual Meeting and Exposition. American Society of Hematology. Orlando, FL.
2011 2011 BMT Tandem Meetings. ASBMT/CIBMTR. Honolulu, HI.
2011 Macroglobulinemia Panel Annual Guidelines Update Meeting. National Comprehensive Cancer Network. Philadelphia, PA.
2011 ASCO 11th Annual Meeting. American Society of Clinical Oncology. Chicago, IL.
2011 37th Annual European Group for Blood and Marrow Transplantation. EBMT.
2011 CALGB Spring Meeting. Cancer & Leukemia Group B Clinical Research Group. Chicago, IL.